Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Speculative Stocks to Exit Before They Get Slammed

By Tyrik Torres, InvestorPlace Contributor
These three speculative stocks to sell are not worth the risk and could send investors' portfolio values plummeting.

SDZNY Stock: 7 Things to Know as Novartis Spinoff Sandoz Starts Trading Today

By William White, InvestorPlace Writer
Sandoz (SDZNY) stock is a hot topic among traders on Wednesday as the company starts trading after a spinoff from Novartis.

Why Is Tilray (TLRY) Stock Down 4% Today?

By William White, InvestorPlace Writer
Tilray has released its earnings report for its fiscal first quarter of 2024 and mixed results have TLRY stock on a wild ride today!

Short Sellers Are Betting Against Novavax (NVAX) Stock

By Dana Blankenhorn, InvestorPlace Contributor
Shorts are betting no one will want Novavax's Covid-19 vaccine, but the pandemic is not yet over, and NVAX stock is cheap.

Why Is Gain Therapeutics (GANX) Stock Moving Today?

By William White, InvestorPlace Writer
Gain Therapeutics stock is on the move Wednesday as investors in GANX react to updated clinical trial news from the company.

Why Is Sonendo (SONX) Stock Up 38% Today?

By William White, InvestorPlace Writer
Sonendo stock is on the rise Wednesday despite the medical technology company recently receiving a delisting notice for SONX shares.

Sure Winners: 7 Stocks Set to Outperform in the Next Recession

By Yiannis Zourmpanos, InvestorPlace Contributor
These titans boast a unique combination of financial resilience, innovative vision, and adaptability that sets them apart in economic adversity.

Glucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn

By Larry Ramer, InvestorPlace Contributor
Diabetes stocks have retreated excessively on the belief that a new weight-loss drug will greatly reduce the number of diabetes patients.

3 Explosive Cannabis Stocks That Will Make Early Investors Rich

By Josh Enomoto, InvestorPlace Contributor
With momentum brewing in the regulatory ranks, intrepid investors may want to consider cannabis stocks to make you rich.

Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich

By Yiannis Zourmpanos, InvestorPlace Contributor
Are you looking to invest in biotechnology breakthroughs? Here are three biotech stocks that could make early investors rich.

SDC Stock Alert: Prepare for SmileDirectClub’s Nasdaq Delisting Tomorrow

By Samuel O'Brient, InvestorPlace Reporter
SmileDirectClub has declared bankruptcy and is about to stop trading on the Nasdaq. As of tomorrow, there will no longer be a SDC stock.

3 Long-Term Stocks to Exit While You Still Can

By Joel Baglole, InvestorPlace Contributor
Whether poor financial results or negative outlooks and ratings from analysts, some stocks are free falling right now. And as the saying goes, investors should never try to catch a falling knife.

Why Is Point Biopharma (PNT) Stock Up 84% Today?

By William White, InvestorPlace Writer
Point Biopharma stock is heading higher on Tuesday as investors react to news of Eli Lilly acquiring the shares of PNT for $12.50 each.

Why Is SmileDirectClub (SDC) Stock Down 25% Today?

By William White, InvestorPlace Writer
SmileDirectClub stock is taking a beating on Tuesday as strong trading of SDC shares continues following its bankruptcy announcement!

7 Speculative Stocks Set to Explode Higher

By Thomas Niel, InvestorPlace Contributor
On the search for high-risk, high-reward opportunities? Consider taking a look at these seven speculative stocks.

The 10 Top Stocks to Watch in Q4 2023

By Jeremy Flint, InvestorPlace Contributor
Yesterday's top stock might be today's loser as we exit a very tough September - but these ten companies are ones to watch for 2023.

The 3 Top Value Stocks to Watch in Q4 2023

By Faizan Farooque, InvestorPlace Contributor
Embrace financial growth with top value stocks. Get comprehensive insights and make informed decisions for a prosperous investment journey.

Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs

By Larry Ramer, InvestorPlace Contributor
CAR T therapies have major advantages over traditional cancer drugs. Here are three of the best cancer drug stocks set to benefit from CAR T.

3 Massively Undervalued Dividend Stocks to Buy for High Total Returns

By Faisal Humayun, InvestorPlace Contributor
These massively undervalued dividend stocks are poised for a strong rally in the next 12 to 15 months. By the end of 2024, these undervalued dividend stocks may indeed deliver 40% to 50% total returns.
Load More Articles